In-home diagnostics NeuLine Health offers ambulatory EEG testing that enables in-home brain monitoring, presenting a lower-cost alternative to in-hospital EEG. This positioning can be used to target clinics and hospitals seeking patient-friendly, cost-efficient neurodiagnostic options.

Expanded footprint Recent news shows NeuLine Health expanding offices and services in major markets like Chicago and Phoenix. Use these expansions to approach regional healthcare networks and health systems looking to consolidate neurodiagnostic services and improve access.

Accredited reliability The company is Joint Commission accredited, signaling quality and compliance. Leverage this credibility when engaging payers and hospital administrators prioritizing accredited, standards-aligned diagnostic partners.

Tech-enabled care NeuLine relies on proprietary NeuXNex software and a home-based EEG workflow, highlighting a tech-driven, remote monitoring capability. This can open conversations with IT teams and data-sharing initiatives, as well as value-based care programs.

Revenue opportunity With a revenue range of 10–25 million and a scalable service offering, there is potential to upsell to larger health systems with multi-site needs, as well as partner with telemedicine and concussion clinics seeking remote diagnostic expansion.